This review is a summary of a recent speaker event on Optimising treatment selection and sequencing in advanced renal cell carcinoma: real-world evidence.
The presentation was given by Dr. Daniel Heng, a Staff Medical Oncologist at the Tom Baker Cancer Center in Calgary, Alberta and a Clinical Professor of Medicine at the University of Calgary.
Please login below to download this issue (PDF)